Form 13-F position report

SPRINGWORKS THERAPEUTICS IN

Reported by LORD ABBETT & CO LLC

SWTX CUSIP 85205L107 Manager CIK 0000728100

Reported 0 shares, down 206,054 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 7 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 23490000
2022-03-31 11629000
2022-06-30 0
2024-03-31 114083000
2024-06-30 78126000
2024-09-30 34274000
2024-12-31 34172000
2025-03-31 16499000
2025-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

9 quarters
Quarterly reported position history for SPRINGWORKS THERAPEUTICS IN held by LORD ABBETT & CO LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2025 Reduced 0 -373,874 (-100.0%) 0 $0 2025-08-14
Q1 2025 Reduced 373,874 -571,934 (-60.5%) 0.06% $16,499,000 2025-05-13
Q4 2024 Reduced 945,808 -123,930 (-11.6%) 0.11% $34,172,000 2025-02-14
Q3 2024 Reduced 1,069,738 -1,004,232 (-48.4%) 0.11% $34,274,000 2024-11-14
Q2 2024 Reduced 2,073,970 -243,840 (-10.5%) 0.26% $78,126,000 2024-08-14
Q1 2024 New 2,317,810 +2,317,810 (0.0%) 0.37% $114,083,000 2024-05-09
Q2 2022 Reduced 0 -206,054 (-100.0%) 0 $0 2022-08-12
Q1 2022 Reduced 206,054 -172,953 (-45.6%) 0.03% $11,629,000 2022-05-13
Q4 2021 Added 379,007 +25,091 (7.1%) 0.05% $23,490,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

168 managers reported SPRINGWORKS THERAPEUTICS IN for Q2 2022.

Managers reporting SPRINGWORKS THERAPEUTICS IN in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 7,412,040 +1,365,831 0.02% $182,484,425 12 qtrs
ORBIMED ADVISORS LLC Unchanged 6,028,307 0 2.72% $148,417,000 12 qtrs
Bain Capital Life Sciences Investors LLC Unchanged 4,831,307 0 13.95% $118,947,000 12 qtrs
STATE STREET CORPORATION Added 3,889,249 +2,293,359 < 0.01% $95,753,000 11 qtrs
PERCEPTIVE ADVISORS LLC Reduced 3,867,446 -660,547 2.98% $95,217,000 12 qtrs
ArrowMark Colorado Holdings LLC Added 3,296,350 +1,958,553 0.93% $81,156,000 12 qtrs
VANGUARD GROUP INC Reduced 2,744,117 -136,869 < 0.01% $67,560,000 12 qtrs
BlackRock Inc Added 2,619,457 +316,178 < 0.01% $64,489,000 12 qtrs
Boxer Capital LLC Unchanged 2,075,905 0 3.24% $51,109,000 12 qtrs
Bank of America Corporation Added 1,646,343 +18,856 < 0.01% $40,532,000 11 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 12, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.